查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1508473

分子肿瘤学市场 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Molecular Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

分子肿瘤学市场 - 报告范围

TMR 关于全球分子肿瘤学市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。年期间，考虑2024年为基准年，2034年为预测年。报告也提供了2024年至2034年全球分子肿瘤学市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解分子肿瘤学市场。

市场概况
2023年市场价值 23亿美元
2034 年市场价值 74 亿美元
复合年增长率 11%

该报告深入探讨了全球分子肿瘤学市场的竞争格局。全球分子肿瘤学市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球分子肿瘤学市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034 年全球市场分析与预测

第 5 章：关键见解

  • 主要併购
  • 按地区/全球分類的监管情景
  • 癌症盛行率
  • COVID-19 影响分析

第 6 章：全球市场分析与预测：依产品分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年各产品市场价值预测
    • 仪器
    • 试剂
    • 其他的
  • 按产品分類的市场吸引力

第 7 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按应用分類的市场价值预测
    • 肺癌
    • 乳癌
    • 大肠直肠癌
    • 卵巢癌
    • 胰腺癌
    • 其他的
  • 按应用分類的市场吸引力

第 8 章：全球市场分析与预测：依技术分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年技术市场价值预测
    • PCR（rt-PCR、d-PCR）
    • NGS（次世代定序）
    • 微阵列
    • FISH（萤光原位杂交）
    • 其他的
  • 技术的市场吸引力

第 9 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年最终用户市场价值预测
    • 医院和诊所
    • 诊断实验室
    • 癌症中心和专科诊所
    • 其他（政府和公共卫生机构）
  • 最终用户的市场吸引力

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按国家/地区分類的市场吸引力

第 11 章：北美市场分析与预测

  • 我们
  • 加拿大

第 12 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区

第 13 章：亚太市场分析与预测

  • 中国
  • 日本
  • 印度
  • 澳洲和纽西兰
  • 亚太地区其他地区

第 14 章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 15 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc.
    • Qiagen NV
    • Agilent Technologies, Inc.
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Roche Diagnostics
    • Genomic Health, Inc.
    • Myriad Genetics, Inc.
Product Code: TMRGL86057

Molecular Oncology Market - Scope of Report

TMR's report on the global molecular oncology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global molecular oncology market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global molecular oncology market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the molecular oncology market.

Market Snapshot
Market Value in 2023US$ 2.3 Bn
Market Value in 2034US$ 7.4 Bn
CAGR11%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global molecular oncology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global molecular oncology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global molecular oncology market.

The report delves into the competitive landscape of the global molecular oncology market. Key players operating in the global molecular oncology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global molecular oncology market profiled in this report.

Key Questions Answered in Global molecular oncology Market Report:

  • What is the sales/revenue generated by molecular oncology across all regions during the forecast period?
  • What are the opportunities in the global molecular oncology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Molecular Oncology Market - Research Objectives and Research Approach

The comprehensive report on the global molecular oncology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global molecular oncology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global molecular oncology market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Molecular Oncology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Molecular Oncology Market Analysis and Forecasts, 2020-2034

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Regulatory Scenario by Region/Globally
  • 5.3. Prevalence of Cancer
  • 5.4. COVID-19 Impact Analysis

6. Global Molecular Oncology Market Analysis and Forecasts, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product, 2020-2034
    • 6.3.1. Instruments
    • 6.3.2. Reagents
    • 6.3.3. Others
  • 6.4. Market Attractiveness By Product

7. Global Molecular Oncology Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2034
    • 7.3.1. Lung Cancer
    • 7.3.2. Breast Cancer
    • 7.3.3. Colorectal Cancer
    • 7.3.4. Ovarian Cancer
    • 7.3.5. Pancreatic Cancer
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Application

8. Global Molecular Oncology Market Analysis and Forecasts, By Technology

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Technology, 2020-2034
    • 8.3.1. PCR (rt-PCR, d-PCR)
    • 8.3.2. NGS (Next Generation Sequencing)
    • 8.3.3. Microarray
    • 8.3.4. FISH (Fluorescent in situ-hybridization)
    • 8.3.5. Others
  • 8.4. Market Attractiveness By Technology

9. Global Molecular Oncology Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020-2034
    • 9.3.1. Hospitals and Clinics
    • 9.3.2. Diagnostic Laboratories
    • 9.3.3. Cancer Centers and Specialty Clinics
    • 9.3.4. Others (Government and Public Health Agencies)
  • 9.4. Market Attractiveness By End-user

10. Global Molecular Oncology Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Molecular Oncology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product, 2020-2034
    • 11.2.1. Instruments
    • 11.2.2. Reagents
    • 11.2.3. Others
  • 11.3. Market Value Forecast By Application, 2020-2034
    • 11.3.1. Lung Cancer
    • 11.3.2. Breast Cancer
    • 11.3.3. Colorectal Cancer
    • 11.3.4. Ovarian Cancer
    • 11.3.5. Pancreatic Cancer
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Technology, 2020-2034
    • 11.4.1. PCR (rt-PCR, d-PCR)
    • 11.4.2. NGS (Next Generation Sequencing)
    • 11.4.3. Microarray
    • 11.4.4. FISH (Fluorescent in situ-hybridization)
    • 11.4.5. Others
  • 11.5. Market Value Forecast By End-user, 2020-2034
    • 11.5.1. Hospitals and Clinics
    • 11.5.2. Diagnostic Laboratories
    • 11.5.3. Cancer Centers and Specialty Clinics
    • 11.5.4. Others (Government and Public Health Agencies)
  • 11.6. Market Value Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Application
    • 11.7.3. By Technology
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Molecular Oncology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product, 2020-2034
    • 12.2.1. Instruments
    • 12.2.2. Reagents
    • 12.2.3. Others
  • 12.3. Market Value Forecast By Application, 2020-2034
    • 12.3.1. Lung Cancer
    • 12.3.2. Breast Cancer
    • 12.3.3. Colorectal Cancer
    • 12.3.4. Ovarian Cancer
    • 12.3.5. Pancreatic Cancer
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Technology, 2020-2034
    • 12.4.1. PCR (rt-PCR, d-PCR)
    • 12.4.2. NGS (Next Generation Sequencing)
    • 12.4.3. Microarray
    • 12.4.4. FISH (Fluorescent in situ-hybridization)
    • 12.4.5. Others
  • 12.5. Market Value Forecast By End-user, 2020-2034
    • 12.5.1. Hospitals and Clinics
    • 12.5.2. Diagnostic Laboratories
    • 12.5.3. Cancer Centers and Specialty Clinics
    • 12.5.4. Others (Government and Public Health Agencies)
  • 12.6. Market Value Forecast By Country, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Application
    • 12.7.3. By Technology
    • 12.7.4. By End-user
    • 12.7.5. By Country

13. Asia Pacific Molecular Oncology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product, 2020-2034
    • 13.2.1. Instruments
    • 13.2.2. Reagents
    • 13.2.3. Others
  • 13.3. Market Value Forecast By Application, 2020-2034
    • 13.3.1. Lung Cancer
    • 13.3.2. Breast Cancer
    • 13.3.3. Colorectal Cancer
    • 13.3.4. Ovarian Cancer
    • 13.3.5. Pancreatic Cancer
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Technology, 2020-2034
    • 13.4.1. PCR (rt-PCR, d-PCR)
    • 13.4.2. NGS (Next Generation Sequencing)
    • 13.4.3. Microarray
    • 13.4.4. FISH (Fluorescent in situ-hybridization)
    • 13.4.5. Others
  • 13.5. Market Value Forecast By End-user, 2020-2034
    • 13.5.1. Hospitals and Clinics
    • 13.5.2. Diagnostic Laboratories
    • 13.5.3. Cancer Centers and Specialty Clinics
    • 13.5.4. Others (Government and Public Health Agencies)
  • 13.6. Market Value Forecast By Country, 2020-2034
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Application
    • 13.7.3. By Technology
    • 13.7.4. By End-user
    • 13.7.5. By Country

14. Latin America Molecular Oncology Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product, 2020-2034
    • 14.2.1. Instruments
    • 14.2.2. Reagents
    • 14.2.3. Others
  • 14.3. Market Value Forecast By Application, 2020-2034
    • 14.3.1. Lung Cancer
    • 14.3.2. Breast Cancer
    • 14.3.3. Colorectal Cancer
    • 14.3.4. Ovarian Cancer
    • 14.3.5. Pancreatic Cancer
    • 14.3.6. Others
  • 14.4. Market Value Forecast By Technology, 2020-2034
    • 14.4.1. PCR (rt-PCR, d-PCR)
    • 14.4.2. NGS (Next Generation Sequencing)
    • 14.4.3. Microarray
    • 14.4.4. FISH (Fluorescent in situ-hybridization)
    • 14.4.5. Others
  • 14.5. Market Value Forecast By End-user, 2020-2034
    • 14.5.1. Hospitals and Clinics
    • 14.5.2. Diagnostic Laboratories
    • 14.5.3. Cancer Centers and Specialty Clinics
    • 14.5.4. Others (Government and Public Health Agencies)
  • 14.6. Market Value Forecast By Country, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Application
    • 14.7.3. By Technology
    • 14.7.4. By End-user
    • 14.7.5. By Country

15. Middle East & Africa Molecular Oncology Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product, 2020-2034
    • 15.2.1. Instruments
    • 15.2.2. Reagents
    • 15.2.3. Others
  • 15.3. Market Value Forecast By Application, 2020-2034
    • 15.3.1. Lung Cancer
    • 15.3.2. Breast Cancer
    • 15.3.3. Colorectal Cancer
    • 15.3.4. Ovarian Cancer
    • 15.3.5. Pancreatic Cancer
    • 15.3.6. Others
  • 15.4. Market Value Forecast By Technology, 2020-2034
    • 15.4.1. PCR (rt-PCR, d-PCR)
    • 15.4.2. NGS (Next Generation Sequencing)
    • 15.4.3. Microarray
    • 15.4.4. FISH (Fluorescent in situ-hybridization)
    • 15.4.5. Others
  • 15.5. Market Value Forecast By End-user, 2020-2034
    • 15.5.1. Hospitals and Clinics
    • 15.5.2. Diagnostic Laboratories
    • 15.5.3. Cancer Centers and Specialty Clinics
    • 15.5.4. Others (Government and Public Health Agencies)
  • 15.6. Market Value Forecast By Country, 2020-2034
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product
    • 15.7.2. By Application
    • 15.7.3. By Technology
    • 15.7.4. By End-user
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Company Profiles
    • 16.2.1. Thermo Fisher Scientific Inc.
      • 16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.1.2. Product Portfolio
      • 16.2.1.3. Financial Overview
      • 16.2.1.4. SWOT Analysis
      • 16.2.1.5. Strategic Overview
    • 16.2.2. Illumina, Inc.
      • 16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.2.2. Product Portfolio
      • 16.2.2.3. Financial Overview
      • 16.2.2.4. SWOT Analysis
      • 16.2.2.5. Strategic Overview
    • 16.2.3. Qiagen N.V.
      • 16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.3.2. Product Portfolio
      • 16.2.3.3. Financial Overview
      • 16.2.3.4. SWOT Analysis
      • 16.2.3.5. Strategic Overview
    • 16.2.4. Agilent Technologies, Inc.
      • 16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.4.2. Product Portfolio
      • 16.2.4.3. Financial Overview
      • 16.2.4.4. SWOT Analysis
      • 16.2.4.5. Strategic Overview
    • 16.2.5. Abbott Laboratories
      • 16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.5.2. Product Portfolio
      • 16.2.5.3. Financial Overview
      • 16.2.5.4. SWOT Analysis
      • 16.2.5.5. Strategic Overview
    • 16.2.6. Bio-Rad Laboratories, Inc.
      • 16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.6.2. Product Portfolio
      • 16.2.6.3. Financial Overview
      • 16.2.6.4. SWOT Analysis
      • 16.2.6.5. Strategic Overview
    • 16.2.7. Roche Diagnostics
      • 16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.7.2. Product Portfolio
      • 16.2.7.3. Financial Overview
      • 16.2.7.4. SWOT Analysis
      • 16.2.7.5. Strategic Overview
    • 16.2.8. Genomic Health, Inc.
      • 16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.8.2. Product Portfolio
      • 16.2.8.3. Financial Overview
      • 16.2.8.4. SWOT Analysis
      • 16.2.8.5. Strategic Overview
    • 16.2.9. Myriad Genetics, Inc.
      • 16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.9.2. Product Portfolio
      • 16.2.9.3. Financial Overview
      • 16.2.9.4. SWOT Analysis
      • 16.2.9.5. Strategic Overview

List of Tables

  • Table 01: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 02: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 03: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 04: Global Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 05: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 08: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 09: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 10: North America Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 11: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 13: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 14: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 15: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 18: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 19: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 20: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 23: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 24: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 25: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 28: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 29: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 30: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Molecular Oncology Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 03: Global Molecular Oncology Market Share Analysis, by Product, 2023
  • Figure 04: Global Molecular Oncology Market Share Analysis, by Product, 2034
  • Figure 05: Global Molecular Oncology Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 06: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 07: Global Molecular Oncology Market Share Analysis, by Cancer Type, 2023
  • Figure 08: Global Molecular Oncology Market Share Analysis, by Cancer Type, 2034
  • Figure 09: Global Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 10: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 11: Global Molecular Oncology Market Share Analysis, by Technology, 2023
  • Figure 12: Global Molecular Oncology Market Share Analysis, by Technology, 2034
  • Figure 13: Global Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 14: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 15: Global Molecular Oncology Market Share Analysis, by End-user, 2023
  • Figure 16: Global Molecular Oncology Market Share Analysis, by End-user, 2034
  • Figure 17: Global Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 18: Global Molecular Oncology Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 19: Global Molecular Oncology Market Share Analysis, by Region, 2023
  • Figure 20: Global Molecular Oncology Market Share Analysis, by Region, 2034
  • Figure 21: Global Molecular Oncology Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 22: North America Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 23: North America Molecular Oncology Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 24: North America Molecular Oncology Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 25: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 26: North America Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 27: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 28: North America Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 29: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 30: North America Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 31: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 32: North America Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 33: Europe Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 34: Europe Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 35: Europe Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 36: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 37: North America Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 38: Europe Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 39: Europe Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 40: Europe Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 41: Europe Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 42: Europe Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 43: Europe Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 44: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 45: Asia Pacific Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 46: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 48: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 49: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 50: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 51: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 52: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 53: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 54: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 55: Latin America Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 56: Latin America Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Latin America Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 58: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 59: Latin America Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 60: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 61: Latin America Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 62: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 63: Latin America Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 64: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 65: Latin America Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 67: Middle East & Africa Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 68: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 69: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 70: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 71: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 72: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 73: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 74: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 75: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 76: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034